1. Home
  2. SCLXW vs CCNEP Comparison

SCLXW vs CCNEP Comparison

Compare SCLXW & CCNEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLXW
  • CCNEP
  • Stock Information
  • Founded
  • SCLXW N/A
  • CCNEP 1865
  • Country
  • SCLXW United States
  • CCNEP
  • Employees
  • SCLXW 111
  • CCNEP 790
  • Industry
  • SCLXW Biotechnology: Pharmaceutical Preparations
  • CCNEP Major Banks
  • Sector
  • SCLXW Health Care
  • CCNEP Finance
  • Exchange
  • SCLXW Nasdaq
  • CCNEP Nasdaq
  • Market Cap
  • SCLXW N/A
  • CCNEP N/A
  • IPO Year
  • SCLXW N/A
  • CCNEP N/A
  • Fundamental
  • Price
  • SCLXW $0.38
  • CCNEP $25.16
  • Analyst Decision
  • SCLXW
  • CCNEP
  • Analyst Count
  • SCLXW 0
  • CCNEP 0
  • Target Price
  • SCLXW N/A
  • CCNEP N/A
  • AVG Volume (30 Days)
  • SCLXW 4.0K
  • CCNEP 783.0
  • Earning Date
  • SCLXW 03-07-2025
  • CCNEP 04-17-2025
  • Dividend Yield
  • SCLXW N/A
  • CCNEP N/A
  • EPS Growth
  • SCLXW N/A
  • CCNEP N/A
  • EPS
  • SCLXW N/A
  • CCNEP 2.39
  • Revenue
  • SCLXW $55,152,000.00
  • CCNEP $217,361,000.00
  • Revenue This Year
  • SCLXW N/A
  • CCNEP N/A
  • Revenue Next Year
  • SCLXW N/A
  • CCNEP N/A
  • P/E Ratio
  • SCLXW N/A
  • CCNEP N/A
  • Revenue Growth
  • SCLXW 22.02
  • CCNEP N/A
  • 52 Week Low
  • SCLXW $0.18
  • CCNEP $21.00
  • 52 Week High
  • SCLXW $0.18
  • CCNEP $25.75
  • Technical
  • Relative Strength Index (RSI)
  • SCLXW N/A
  • CCNEP 59.76
  • Support Level
  • SCLXW N/A
  • CCNEP $24.81
  • Resistance Level
  • SCLXW N/A
  • CCNEP $25.06
  • Average True Range (ATR)
  • SCLXW 0.00
  • CCNEP 0.19
  • MACD
  • SCLXW 0.00
  • CCNEP 0.05
  • Stochastic Oscillator
  • SCLXW 0.00
  • CCNEP 94.69

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About CCNEP CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. It derives revenue through the operations as a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional customers. The company branch are located in Pennsylvania, Ohio, New York and Virginia.

Share on Social Networks: